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AIM OF THE STUDY: 
Surgical Site Infections constitute a major portion of post operative morbidity to surgical 
patients and also burden the hospital with significant but avoidable expenditure. 
The use of antibiotics in the management of surgical wounds and prevention of Surgical Site 
Infections is well documented, however literature is varied in its opinion regarding their use 
in clean and clean contaminated cases. Most suggest the use of only prophylactic (pre-op) 
antibiotics but some even go as far as recommending usage of no antibiotics in especially 
clean wounds. Usage into post op period is not advised. Unmonitored, empirical and 
prolonged therapy is fraught with disadvantages like toxicities and antibiotic resistance. 
Hence,  
AIM 1.To ascertain if Class I and Class II procedures require any active intervention for the 
prevention of Surgical Site Infections 
AIM 2.To find out whether the use of cost-effective interventions like prophylactic 
antibiotics alone reduce the incidence of Surgical Site Infections in Class I and Class II 
procedures. 
The creation of surgical wounds include a formation of a neo potential dead space in the 
subcutaneous plane causing possible acute fluid collections which subsequently acts as a 
nidus for infection. The obliteration of this dead space has been proved to decrease the 
incidence of Surgical Site Infections. Many methods have been described, the most 
commonly employed being either absorbable non-irritant suture obliteration or use of 
suction drains. Previous literature has shown drainage under suction to be more efficacious 
hence, 
 7 
 
AIM 3.To find out whether the use of suction drains reduce the incidence of Surgical Site 
Infections in Class I and Class II procedures. 
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OBJECTIVES : 
To study -  
1. Risk factors for SSIs 
2. Prophylactic antibiotics vs. No treatment 
3. Closed suction drainage vs. No treatment 
These aforementioned objectives if fulfilled by scientific means like a RCT, would enumerate 
risk factors for Surgical Site Infections, and find the most efficacious and cost effective 
intervention for prevention of Surgical Site Infections. 
 
KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS 
The definitions of the types of evidence and the grading of recommendations used in this 
guideline originates from the US Agency for Health Care Policy and Research [1] and are set 
out in the following tables. 
 
STATEMENTS OF EVIDENCE 
Ia Evidence obtained from meta-analysis of randomised controlled trials. 
 
Ib Evidence obtained from at least one randomised controlled trial. 
 
IIa Evidence obtained from at least one well-designed controlled study without 
randomisation. 
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IIb Evidence obtained from at least one other type of well-designed quasi-experimental 
study. 
 
III Evidence obtained from well-designed non-experimental descriptive studies, such 
as comparative studies, correlation studies and case studies. 
 
IV Evidence obtained from expert committee reports or opinions and/or clinical 
experiences of respected authorities. 
 
GRADES OF RECOMMENDATIONS 
A Requires at least one randomised controlled trial as part of a body of literature of 
overall good quality and consistency addressing the specific recommendation. 
(Evidence levels Ia, Ib) 
 
B Requires the availability of well conducted clinical studies but no randomised 
clinical trials on the topic of recommendation. 
(Evidence levels IIa, IIb, III) 
 
C Requires evidence obtained from expert committee reports or opinions and/or 
clinical experiences of respected authorities. Indicates an absence of directly 
applicable clinical studies of good quality. 
(Evidence level IV) 
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Therefore as the chosen form of analytical study is a Randomized Controlled Trial – this 
study is a CLASS I evidence study and its resultant recommendations are Level 1. 
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INTRODUCTION: 
Surgical site infections (SSIs) are a real risk associated with any surgical procedure and 
represent a significant burden in terms of patient morbidity and mortality, and cost to 
health services around the world. Surgical wound infection is a common postoperative 
complication and causes significant postoperative morbidity and mortality, prolongs 
hospital stay, and adds between 10% and 20% to hospital costs. 
 
Surgical site infections are the 3rd most common post op infection in surgical patients after 
urinary tract and respiratory tract infections. [2] 
 
In cases of deep or extensive infection this resulted in a mortality rate of 70-80% [3]. 
Most SSIs are superficial, but even so they contribute greatly to the morbidity and mortality 
associated with surgery [4] [5]. Surgical site infections are usually secondary to inoculation 
of bacteria from patients own endoflora (eg. Anterior nares, mouth, rectum) and less often 
from the environment. 
Definition of SSI: Any purulent discharge from a closed surgical incision, together with 
signs of inflammation of the surrounding tissue should be considered as wound infection, 
irrespective of whether micro-organisms can be cultured. Infection can occur at an incision 
site within 30 days of an operation, but if an implant is placed (eg. Arthroplasty, mesh) the 
definition is extended upto 1 year.  
 
There are intermediate categories of wounds that may or may not be infected—namely, 
wounds that have a small amount of clear discharge. These wounds maybe considered as 
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'possibly' or 'probably' infected. In 1992, the Surgical Wound Infection Task Force replaced 
the term 'surgical wound infection' with ‘surgical site infection', to include infections of 
organs or spaces deep in the skin and soft tissues, such as peritoneum and bone. Surgical 
site infection is classified into superficial site infection and organ or space infection. 
 
Types of SSI : 
 
 
Superficial Incisional SSI 
Deep Incisional SSI
Organ / Space SSI
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CRITERIA  FOR TYPES OF SSI [6] 
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CDC Classification of Surgical Wounds[7] 
Classification of operative wounds based on degree of microbial contamination 
Classification Criteria 
Clean 
Elective, not emergency, non-traumatic, primarily closed; no acute 
inflammation; no break in technique; respiratory, gastrointestinal, biliary 
and genitourinary tracts not entered.  
Clean-
contaminated 
Urgent or emergency case that is otherwise clean; elective opening of 
respiratory, gastrointestinal, biliary or genitourinary tract with minimal 
spillage (e.g. appendectomy) not encountering infected urine or bile; minor 
technique break.  
Contaminated 
Non-purulent inflammation; gross spillage from gastrointestinal tract; entry 
into biliary or genitourinary tract in the presence of infected bile or urine; 
major break in technique; penetrating trauma <4 hours old; chronic open 
wounds to be grafted or covered.  
Dirty 
Purulent inflammation (e.g. abscess); preoperative perforation of 
respiratory, gastrointestinal, biliary or genitourinary tract; penetrating 
trauma >4 hours old.  
 
Infection rates in the four surgical classifications (clean, clean-contaminated, contaminated 
and dirty wounds) have been published in many studies but most literature refers to the 
work of Cruse and Ford as a benchmark for infection rates [8][9]. Before the routine use of 
prophylactic antibiotics infection rates were 1-2% or less for clean wounds, 6-9% for clean-
contaminated wounds, 13-20% for contaminated wounds and about 40% for dirty 
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wounds[8][9]. Since the introduction of routine prophylactic antibiotic use, infection rates in 
the most contaminated groups have reduced drastically. Infection rates in US National 
Nosocomial Infection Surveillance (NNIS) system hospitals were reported to be: clean 2.1%, 
clean-contaminated 3.3%, contaminated 6.4% and dirty 7.1% [10]. There is, however, 
considerable variation in each class according to the type of surgery being performed [11] 
Systematic review of Indian literature suggests a wide average reported range of incidence 
of SSIs 2.5 to 41.9% in Class I and II wounds. ( 4.04 to 30% in class I and 10.06 to 45% in class 
II ) [12 – 18] 
RISK FACTORS FOR SSIs[19-20] 
Risk or predisposing factors for the development of SSIs can be broadly classified into 3 
groups – 
 Host 
 Environment  
 Procedural 
1. Host  
Pre existing illnesses like diabetes, renal failure, jaundice, anaemia and other co-
morbidities –  
The American Society of Anaesthesiologists (ASA) has devised a preoperative risk 
score based on the presence of co-morbidities at the time of surgery. An ASA score 
>2 is associated with increased risk of wound infection and this risk is 
              additional to that of classification of operation and duration of surgery 
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The American Society of Anaesthesiologists (ASA) preoperative assessment score, 
was validated in a large study involving 44 hospitals from 1987 to 1990. 
The wound infection rate among patients in ASA class I or II was 1.9%, whereas 
among patients in class III to V was 4.3%. Garibaldi et al have since confirmed the 
independent predictive power of the ASA score in a prospective study of 1852 
surgical patients in which the odds ratio of having a wound infection for ASA class III 
to V patients compared with Class I or II patients was 4.2.[21,6] 
                      
Extremes of age 
Obesity (>20% of ideal body weight) 
Smoking or alcohol consumption 
Bacterial colonization of anterior nares with S.aureus 
Remote site infection 
Duration of preoperative hospital stay (significant if more than 14 days) – Kowli et al 
found stay <1 week risk is 17.4% and if >3 weeks it is almost 71.4%. Similarly Anvikar 
et al found for stay less than 1 day risk was ~1.7% but for >1 week it was almost 5%  
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Immunosuppressed status 
 
2. Environment 
Theatre environs incl. cleanliness, sterilization, ventilation 
Previous case operated on the same table (if contaminated or dirty the risk of SSI in 
subsequent cases increase) 
Microbe related – common pathogens, its virulence and resistance patterns 
 
3. Procedural or operation based 
Pre op preparation( skin – scrub and method used; hair removal – best 
recommended is electroepilation; sterile techniques like hand washing, painting and 
draping, gloving) 
Meticulous surgical technique like tissue handling with minimal devitalization, 
surgeon expertise, strict haemostasis, use of excessive electro cautery in the 
subcutaneous plane 
Length of surgery–Duration of surgery is positively associated with risk of wound 
infection and this risk is additional to that of the classification of operation.[10] In 
this study by Culver et al, operations that lasted longer than the 75th percentile for 
the procedure were classified as prolonged. The 75th percentile is based on data 
 18 
 
from the USA. These times have not been evaluated or confirmed by studies in the 
UK. 
Cruse and Foord found that the rate of wound infection increased for longer 
procedures, roughly doubling with every hour of the procedure. Operations lasting 1 
hour or less had a wound infection rate of 1.3%, whereas those lasting3 hours or 
more had a rate close to 4.0%. Haley et al showed by using multivariate analysis that 
an operative time of more than 2 hours is the second greatest independent predictor 
of risk (wound contamination being the first)[22] 
Antibiotic prophylaxis regimen 
Foreign material in surgical wound inclusive of Drains - Insertion of any prosthetic 
implant increases the risk of infection of the wound and surgical site. The implant 
has a detrimental effect on the patient’s host defences. As a result, a lower bacterial 
inoculum is needed to cause infection of a prosthetic implant than of viable tissue. 
Thus the chance of infection is increased [23] 
Post operative hypothermia and hypotension [24] 
 
PROBABILITY OF SSIs 
Previous guidelines have referred to patients who are at high risk of SSI but have not 
provided clear information about prediction of risk. This section is intended to illustrate 
how co-morbidity and duration of operation add to the risk defined by type of operative 
wound. 
Duration of surgery and co-morbidities have as great an impact on the risk of wound 
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infection as the operation classification. 
The presence of the two risk factors co-morbidity (as indicated by an ASA score >2) and 
duration of operation (>75th percentile) can be used to calculate a “risk index”, where: 
 
Risk index 0 = when neither risk factor is present 
Risk index 1 = when either one of the risk factors is present 
Risk index 2 = when both risk factors are present. 
 
For example, below illustrated Table was derived from a large epidemiological study of 
hospital acquired infection in which a risk score from a previous study was validated and 
refined. In this study, the risk of wound infection with a clean wound plus both additional 
risk factors was greater than the risk for a contaminated wound with no additional risk 
factors (5.4% versus 3.4%). 
 
(or) 
NNIS SCORING SYSTEM (Culver et al, 1991) 
 Procedure time > 75th percentile / for convenience > 2 hours 
 Contaminated / dirty wounds 
 ASA III – V 
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No. of risk factors Risk 
0 1-2% 
1 2-4% 
2 5-10% 
3 10-15% 
 
 
ANTIBIOTIC PROPHYLAXIS – An overview 
Introduction 
Burke[25] demonstrated the importance of the timely use of prophylactic antibiotics in 
surgery.  Antibiotic prophylaxis can decrease postoperative morbidity, shorten 
hospital stay, and reduce overall costs attributable to infection. 
 
Limiting the use of antibiotic prophylaxis to the intra-operative period is one of the most 
significant changes in preventing infection and is dramatically different from the previously 
recommended 24 to 48hour coverage. Single-dose prophylaxis is effective in most surgical 
procedures. Additional, prolonged antibiotic prophylaxis while lines, tubes, and catheters 
are in situ is not necessary. The use of antibiotic prophylaxis is not a substitute for good 
infection control practices, proper patient preparation, good judgement, good technique, or 
an adequate operating environment. Inappropriate and indiscriminate use of prophylactic 
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antibiotics may increase costs through unnecessary drug use, requisite laboratory 
monitoring, and the emergence of resistant organisms. The potential toxicity of antibiotics is 
also an important risk of antibiotic prophylaxis.[26] 
 
The goals of prophylactic administration of antibiotics to surgical patients are to: 
 reduce the incidence of surgical site infection 
 use antibiotics in a manner that is supported by evidence of effectiveness 
 minimise the effect of antibiotics on the patient’s normal bacterial flora 
 minimise adverse effects 
 cause minimal change to the patient’s host defences. 
 
It is important to recognize the difference between prophylactic and empiric therapy. 
Prophylaxis is indicated for procedures associated with high infection rates, those involving 
implantation of prosthetic material, and those in which the consequences of infection are 
serious. The antibiotic should cover the most likely contaminating organisms and be present 
in the tissues when the initial incision is made. Therapeutic concentrations should be 
maintained throughout the procedure. Empiric therapy is the continued use of 
antibiotics after the operative procedure based upon the intra-operative findings. Empiric 
antibiotic therapy is addressed in a separate guideline. Inappropriate prophylaxis is 
characterized by unnecessary use of broad-spectrum agents and continuation of therapy 
beyond the recommended time period. These practices increase the risk of adverse effects 
and promote the emergence of resistant organisms. 
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For most surgical procedures, a single bolus of intravenous antibiotic at the time of  
induction of anaesthesia or within 1 hour of skin incisions considered adequate. This dose 
enables a high plasma and tissue concentration to be attained rapidly. The rate of infection 
increases if prophylactic antibiotics are given more than 2 hours preoperatively, or 
postoperatively. Oral and intramuscular routes of administration produce a lower peak 
plasma level. [27-28] 
 
The least toxic and most effective antibiotic regimen should be chosen. Choice should also 
based on local and current trends on prevalent pathogens and their sensitivity patterns. 
 
The dose of prophylactic antibiotics should not be smaller than the standard therapeutic 
dose of the drug. A single prophylactic dose is effective and preferred to multiple doses. The 
single dose approach has the advantage of low cost, less toxicity, and less chance of 
developing antibiotic resistance.[29] 
 
What is the “Decisive period” and why does the antibiotic have to be given within one 
hour of skin incision? 
After skin incision there is breakdown of the normal epithelial and immune barrier and 
hence inoculation of pathogenic bacteria into the wound depths is an imminent possibility. 
Therefore at the time of skin incision maximum blood concentration of the antibiotic should 
be present. The time taken for an antibiotic to reach an effective concentration in any 
particular tissue reflects its pharmacokinetic profile and the route of administration.[30] 
After incision the immune system takes about 4 hours to mobilize an acute inflammatory 
response of cells and proinflammatory substances at the site of injury thereby being able to 
 23 
 
combat any infection seeded in the wound. Hence, antibiotics given preoperatively must be 
chosen and given appropriately so as to protect the wound in those first 4 hours of apparent 
risk. 
Antibiotic chosen must have a half life that is almost 4 hours, does not have excessive first 
pass metabolism and must be given intravenously as it provides more consistent and 
maximal blood concentrations. 
 
Risks of prophylaxis[31-37] 
One of the aims of rationalising surgical antibiotic prophylaxis is to reduce the inappropriate 
use of antibiotics thus minimising the consequences of misuse. Rates of antibiotic resistance 
are increasing in all hospitals. The prevalence of antibiotic resistance in any population is 
related to the proportion of the population that receives antibiotics, and also the total 
antibiotic exposure. 
An additional problem is the dramatic increase in the number of cases of colitis caused 
by Clostridium difficile. The prevalence of C. difficile infection is related to total 
antibiotic usage and, in particular, to the use of third generation cephalosporins. In 
epidemiological studies of C. difficile colitis, surgical antibiotic prophylaxis is the single 
most common indication for use of antibiotics. Although even single dose prophylaxis 
increases the risk of carriage of C. difficile, in a case control study of patients all of 
whom received surgical prophylaxis C. difficile was more common in patients who 
received prophylaxis for >24 hours (56% vs. 17%). 
 
Choice of antibiotic 
The antibiotics chosen for prophylaxis can be those used for active treatment of infection. 
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However, the chosen antibiotics must reflect local, disease-specific information about 
the common pathogens and their antimicrobial susceptibility. 
A past history of a serious adverse event should preclude administration of a particular 
antibiotic. 
 
Patients with a history of anaphylaxis or urticaria or rash occurring immediately after 
penicillin therapy are at increased risk of immediate hypersensitivity to penicillins and 
should not receive prophylaxis with a beta-lactam antibiotic. 
 
Timing of administration 
As aforementioned the best time for is within 30-60 minutes before skin incision. (for 
protocol purposes literature does mention it to be at induction) [38-39] 
 
Duration of prophylaxis and additional dosages 
As mentioned before based on the decisive period concept the prophylactic effect must last  
atleast 4 hours. 
 
Many of the drugs used in prophylaxis have relatively short half lives (1-2 hours in studies of 
normal volunteers). In such situations it may therefore seem logical to give an additional 
dose of prophylaxis during operations that last for more than 2-4 hours. However, in 
comparison with normal volunteers, patients undergoing surgery have slower clearance of 
drugs from their blood. This is probably due to a combination of factors. For example, in 
comparison with normal volunteers, surgical patients are older(and therefore have poorer 
renal function) and have more co-morbidities. The limited data available show that drugs 
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such as cefuroxime, which has a half life of 1-2 hours in normal volunteers have a half life of 
2-4 hours in patients at the time of surgery, and that effective concentrations are 
maintained for at least five hours after the start of surgery.[40-41] 
 
In all operations the administration of additional doses after the end of surgery does not 
provide any additional prophylactic benefit. Individual studies claiming to support 
additional postoperative doses are methodologically flawed. For example, not blinding 
observers to treatment allocation and including culture of bacteria from a wound swab 
as an indication of wound infection. This is specifically excluded from most definitions 
of wound infection, as the test does not distinguish between colonisation and infection. 
Moreover, patients who are continuing to receive antibiotics are clearly less likely to have 
bacteria grown from swabs than patients who are not receiving antibiotics.[7,42-46] 
Prophylaxis should be confined therefore to the perioperative period (i.e. administration 
immediately before or during the procedure). Postoperative doses of antibiotic for 
prophylaxis should not be given for any operation. Any decision to prolong prophylaxis 
beyond a single dose should be explicit and supported by an evidence base. 
 
Route of administration 
Intravenous administration of antibiotic prophylaxis immediately before induction of 
anaesthesia is the most reliable method for ensuring effective serum antibiotic 
concentrations at the time of surgery. 
Serum concentrations after oral or intramuscular administration are determined in part 
by the rate of absorption, which varies between individuals. There is relatively little 
evidence about the effectiveness of orally or intramuscularly administered antibiotic 
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prophylaxis. A further problem is that often the correct time of administration is difficult 
to guarantee in practice, because, for example, it occurs without the theatre environment. 
 
Dosage  
The single dose of antibiotic for prophylactic use is, in most circumstances, the same as 
would be used therapeutically. 
 
Blood loss, fluid replacement and antibiotic prophylaxis[47-50] 
Serum antibiotic concentrations are reduced by blood loss and fluid replacement, 
especially in the first hour of surgery when drug levels are high. 
The precise effects of blood loss and fluid replacement are difficult to predict, depending 
on the timing and rate of loss and replacement. However, in adults the impact of 
intraoperative bleeding and fluid replacement on serum drug concentrations is usually 
negligible. 
An additional dose of prophylactic agent is not indicated in adults, unless there is 
blood loss of up to 1500 ml during surgery or haemodilution of up to 15 ml/kg. 
In the event of major intraoperative blood loss (>1500 ml), additional doses of 
prophylactic antibiotic should be given after fluid replacement. 
Fluid replacement bags should not be primed with prophylactic antibiotics because 
of the potential risk of contamination and calculation errors. 
 
These guideline does not cover the following types of surgery: 
 prevention of urinary tract or respiratory tract infections after elective surgery, with 
the exception of urinary tract infection after transurethral resection of the prostate 
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 use of antiseptics or topical antibiotics (e.g. tetracycline peritoneal lavage, 
subconjunctival injections for cataract surgery) for the prevention of wound        
infection after elective surgery 
 treatment of anticipated infection in patients undergoing emergency surgery for 
contaminated or dirty operations 
 administration of oral antibiotics for bowel preparation or to achieve selective 
decontamination of the gut 
 
CLOSED SUCTION DRAINAGE – An overview 
The dead space created during surgery in the subcutaneous plane can result in the 
formation of an acute fluid collection or seroma from minimal oozing from blood vessels or 
lymphatics or from fat lysis secondary to usage of excess diathermy to control small calibre 
bleeders during skin incision and deepening. This acute fluid collection when secondarily 
infected can result in a surgical site infection. 
Therefore obliteration of this dead space would benefit in two ways –  
a. Reduction of potential space into which any fluid could collect 
b. Apposition of the walls of this space can act as a tamponade effect which could 
curtail further ooze from minor vessels. 
Many methods have been suggested to decrease dead space such as, decreased dissection 
in this plane, use of absorbable non braided suture and insertion of drains either under 
suction or free open type. 
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A limited amount of literature has been published regarding the latter 2 methods. 
Studies on mastectomy, axillary dissection and caesarean section (Pfannensteil) incisions are 
available which state emphatically the superiority of firstly drainage of space when 
compared with suture closure – probably because of impregnation of bacterial inoculum in 
the fibre and the lack of removal of the “foreign body” suture in the long run. Secondly 
suction drainage is better than free open drains (eg. Penrose) as the suction apparatus 
would prevent retrograde flow inoculation via the tubing and also provide a faster and more 
sustained evacuation of any resultant post operative fluid collection.[51-55] 
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HYPOTHESES : 
1. To reduce SSIs - use of any of the 2 interventions (antibiotic, closed suction drain) 
is superior to no intervention at all. 
 
2. To ascertain which of the above 2 interventions is the most effective at reducing  
the incidence of SSIs. 
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MATERIALS AND METHODS: 
PLACE OF STUDY: 
This study was conducted at the Dept. Of General Surgery at Stanley Medical College, 
Chennai. All cases admitted in the surgical unit headed by Prof. Darwin if fitting the stringent 
inclusion criteria were added. 
 
STUDY PERIOD: 
The study undertaken was for a period of one year- from  November 2009 to November 
2010. 
 
STUDY DESIGN: 
A Randomized prospective controlled trial to compare each intervention. 
Patients will be randomly allocated into the 3 above mentioned study groups (no. 1 to 3) 
using a computer generated random number table.   
Using available literature, the incidence of SSIs without the use of any intervention was 
found to be 30%, while the use of prophylactic antibiotics was found to decrease the SSIs to 
15%. Similarly, the use of closed suction drain reduced the incidence of SSIs to 10%. Using 
these values and the formula given below the sample size was found to be 118 and 59 for 
each arm and total sample size was calculated to be 295.  
The formulas used to calculate sample size was                                          
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n = {Z (1-α/2) +Z  1-β }2 *π1( 1- π1) + π2(1- π2 )] /  (π1- π2)
2   
which is a formula used  when dealing with discrete data, to calculate the difference 
between proportions. 
Statistical analysis will be done by- Fischer’s Exact test or the Chi-square test. 
INCLUSION CRITERIA : 
1. All Class I and II (emergency/elective) operative procedures 
2. Age >=15 years 
3. Subjects who have given their informed consent  
4. Subjects willing to follow up on Day 7,30 or earlier as indicated 
5. Incision length >=6 cms 
 
EXCLUSION CRITERIA : 
1. All Class III and IV operative wounds 
2. ASA III - V 
3. More than 3 co-morbidities predisposing to SSIs 
4. Attrition due to no follow up or to death 
5. Antecedent planned operative site infection 
6. Allergy to antibiotics used in study  
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METHODOLOGY: 
Patients of class I and II were randomly allocated into the 3 study groups 
( 1=Control/No treatment; 2= prophylactic Antibiotics; 3= Suction drain). 
Risk of developing SSI were calculated using NNIS System  
All subject details were tabulated using the after mentioned pre tested proforma which 
includes demographic data, operative details, study group, clinical examination, radiological 
investigations, appropriate cultures, treatment of SSI if any.  
In the case of group 1 subjects-no antibiotic was given preoperatively and no obliteration of 
dead space done, thus allowing natural history of wound healing to take its course. 
In the case of Group 2 subjects the following prophylactic antibiotics were administered 
within one hour of skin incision (best protocol is : at induction)  
Antibiotic used in GI cases – Cefotaxime plus metronidazole 
Antibiotic used in General cases (eg. Breast, thyroid, soft tissue)–Cefotaxime plus 
Gentamycin. 
In the subjects belonging to Group 3- For obliteration of dead space, closed suction drain    [ 
infant feeding tube / standard suction catheter (12 – 14F) connected to 10ml syringe or 
other appropriate suction devices ] was inserted in the intra-operative period after wound 
irrigation with normal saline. Overlying skin was closed with standard skin suturing 
techniques. 
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Drains were monitored for daily output and character of fluid, drains were retained till 
output was less than 2 ml per day or if infection precluded opening of the wound and 
resultant loss of closed space vacuum action. 
All cases followed up in post operative period during hospital stay (note : dressings not 
removed till 48 hours unless indicated ), day 7, day 30  
Wound surveillance done using AEPSIS scoring system. Assessment of healing and infective 
complications was made using the asepsis wound scoring system[56] as recommended by 
the Surgical Infection Study Group. [57] This describes the appearance of the wound and the 
necessity for further treatment, such as the administration of antibiotics. The maximum 
score is 70. It is very sensitive and allows objective appraisal of infection, and its severity. 
For the purpose of our study, a score of 0 to 10was considered to represent normal wound 
healing, and a score of more than 10 an infection. This confers a sensitive, if arbitrary, 
definition of infection. A single neutral observer (CPL) recorded the scores at 5 days and 30 
days after operation. The highest score for each patient was adopted. 
 
ASEPSIS SCORING SYSTEM 
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RESULTS AND OBSERVATIONS 
The trial was conducted for a period of one year during which 235 subjects were 
included.(adhering to strict inclusion and exclusion criteria)  However 19 subjects were lost 
to follow up and hence the final number after attrition is 216. 
The subjects were randomly included in the 3 study groups using a random number table. 
Sex distribution : 
The number of male subjects :125 
The number of female subjects :91 
 
 
 
 
125
91
Sex Distribution
MALES
FEMALES
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Age Distribution: 
The age wise distribution of subjects is depicted in the graph below. 
Maximum number was seen in the 15 – 25 years age group, followed by 36 – 45 years.  
 
 
To test whether age independently influences the outcome viz. SSI – the study population 
was divided into less and more than 45 years. 
Subjects <45years :151   No. of subjects with SSI:44     No. of subjects without SSI:107 
Subjects > 45 years: 65   No. of subjects with SSI:26     No. of subjects without SSI:39 
The Chi-Square and Fischer’s test was applied to the above discrete data and the two-tailed 
P value equals 0.1533, the p value obtained was not statistically significant , hence according 
to this trial the age factor did not influence the occurrence of a SSI in subjects, and the 
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difference in incidence of SSIs in the 2 age distributions was due to chance or due to 
spurious sampling. 
 
Class of operation: 
The total number of 54 class I surgeries performed was and class II was 162. 
Among Class I surgeries 12 developed SSI (22.22 %) while in Class II surgeries 57 developed 
SSI (35.19 %) 
Study group wise – 
 Control group :  
Class I surgeries – 19        SSI developed in - 7 SSI not developed in -12 
Class II surgeries – 66       SSI developed in-34 SSI not developed in -32 
 
 Prophylactic antibiotic group : 
Class I surgeries –22        SSI developed in - 4 SSI not developed in -18 
Class II surgeries-62         SSI developed in-7 SSI not developed in -45 
 
 Closed suction drain group : 
Class I surgeries –13        SSI developed in - 1 SSI not developed in -12 
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Class II surgeries – 34      SSI developed in-6 SSI not developed in -28 
 
Types of surgeries done and their respective class of surgery as per CDC classification: 
Sl. No. Type of Surgery Number 
Performed 
CDC Classification of 
Surgery and wound 
1 Adhesiolysis 2 II 
2 Anatomical + Mesh repair of ventral 
hernia 
7 II 
3 Anatomical Repair 5 I 
4 Appendicectomy 68 II 
5 Hernioplasty 62 II 
6 Herniotomy 6 I 
7 Herniorraphy 3 I 
8 Trendelenburg operation  3 I 
9 Cystogastrostomy for pseudocyst 1 II 
10 Cholecystectomy 7 II 
11 Thyroidectomy (Hemi, Near Total, 
Total) 
6, 1, 1 = 8 I 
12 Distal Pancreatectomy + 
Splenectomy 
2 II 
13 Soft Tissue Excisions 16 I 
14 Orchidectomy 2 I 
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15 Laparotomy and Biopsy 1 II 
16 Mayo Repair 1 I 
17 Mesh repair for ventral hernia 2 II 
18 Palliative Ant. GJ 2 II 
19 Bowel reanastomosis 1 II 
20 Total parotidectomy + MRND 1 I 
21 Ilio – inguinal block dissection 1 I 
22 Salpingo-oopherectomy 3 II 
23 Subtotal excision of hydrocele sac 3 I 
24 Sistrunk procedure 2 I 
25 Truncal Vagotomy + GJ 3 II 
26 Total Abdominal Hysterectomy 2 II 
27 Splenectomy 1 I 
38  High Femoral hernia repair 1 I 
 
 
Predisposing Factors : 
A number of predisposing factors were studied during this trial. 
Environmental and procedural factors were relatively constant in all subjects hence did not 
contribute to the final outcome viz. SSI. 
Cases were operated (on emergency and elective basis) on a table always following theatre 
washing and scrubbing between cases. 
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Pre op preparation was with bathing the night to prior to elective surgery and immediately 
preceding emergency surgery. Hair removal was done by shaving with sterile razor blades. 
Standard hand washing techniques were employed with iodine based scrubs and Sterilium© 
disinfection. Standard operative field painting done with iodine based solution, thrice. 
Draping done with sterile linen. Meticulous technique in handling of tissue followed at all 
times. Use of diathermy in the parietal layers limited to control of bleeding vessels only and 
not used indiscriminately for opening tissue planes by electro-cutting or coagulation modes. 
Strict haemostasis was ensured at the end of surgery before closing parietal layers.  
Tobacco and alcohol consumption was almost a universal factor among the male subjects 
and hence not considered a factor in this trial. Besides all patients were abstinent from 
tobacco and alcohol consumption for a minimum of 2 weeks prior to elective surgery as per 
anaesthetic orders, thereby alleviating the acute deleterious effects of the same. Only in 
emergency cases such abstinence could not be ensured. 
The predisposing factors encountered which could have a direct bearing on the outcome by 
affecting wound healing were – comorbidites like obesity/malnutrition, anaemia, 
diabetes(maximum) , hypertension, immunosuppression and increased (more than 14 days) 
of preoperative hospital stay. 
Among the subjects who developed SSIs –  
20 had a predisposing factor, 10 had more than 1 predisposing factor and 39 had none, in 
the overall trial population. 
10 had a predisposing factor, 4 had more than 1 predisposing factor and 28 had none, in the 
control group respectively. 
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Most commonly encountered was Diabetes mellitus, the rest included – hypertension, 
obesity, malignancy, old age, anaemia, prolonged preoperative hospital stay, long duration 
of surgery and immunosuppression ( due to HIV infection and previous radiotherapy to a 
different anatomical site ).  
 
 
Tests of statistical significance was performed and the result was –  
 Control group  
 FACTOR PRESENT NO FACTOR 
SSI DEVELOPED 14 27 
SSI NOT DEVELOPED 6 38 
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Fischer’s test was performed and the two-tailed P value obtained was 0.0396 – hence 
considered to be  statistically significant. 
 
 Overall population 
 FACTOR PRESENT NO FACTOR 
SSI DEVELOPED 30 39 
SSI NOT DEVELOPED 26 147 
 
Fischer’s test was performed and the two-tailed P value obtained was 0.0001 – hence 
considered to be extremely statistically significant. 
Hence the conclusion that can be drawn is that the presence of predisposing factors does 
predispose the subject to develop a SSI in the post op period.  
 
Elective vs. Emergency surgeries and its significance : 
A total of 74 cases were operated on an emergency basis and a total of 146 cases were 
operated on elective basis respectively. The final outcome in these 4 sub groups was – 
 Control gp 
with SSI 
Control gp 
without SSI 
Total population 
with SSI 
Total population 
without SSI 
ELECTIVE 31 29 50 94 
EMERGENCY 11 14 18 54 
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Test of statistical significance applied on the control subset and total population to compare 
if performing a surgery as elective or emergency basis could alter the chance of developing 
SSI, the result was –  
 Control group - The two-tailed P value equals 0.6354, hence found to be not statistically 
significant. 
 Overall population - The two-tailed P value equals 0.1641, hence found to be not 
statistically significant. 
Hence the conclusion that can be drawn is that performing a operation ( either class I/II 
procedures ) on elective or emergency basis does not influence the outcome of incidence of 
SSIs. 
 
Surgical site infections – the outcome 
Most SSIs were anatomically of the superficial incisional type (95.65 %), deep incisional type 
accounted for cases (4.35 %) and there were no tissue / organ space infections. 
Most wound infections according to literature begin to occur from post operative day 4 
onwards, with the rare entities of streptococcal/clostridial infection and wound dehiscence 
or contamination from gastro-intestinal or biliary/pancreatic  anastomotic leaks occurring 
within the first 3 days of the post operative period.  
In this trial – 68 patients developed SSI within 7 days( 98.55 % ) , no patients developed 
earlier than post op day 3.Mostcommonly infections began on day 4 and 5. 
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Only 2 patients developed late onset SSI ( 2.89 % ) viz. Post 7 days in the post operative 
period but within 1 month of day of surgery. Both were cases of hernia repair with mesh 
placement. 
 
Bacteriology of SSIs : 
All exudation from the wound was swabbed using sterile techniques and sent for 
bacteriological analysis to obtain the nature, virulence and antibiotic sensitivity patterns of 
the inoculum. The empirically started antibiotic after noting the occurrence of a SSI  (wound 
swab always preceded antibiotic initiation) can be hence changed to a more suitable 
antibiotic the organism is sensitive to.  
It however must be noted that culture negative or positive wound is not considered a gold 
standard for the exclusion or presence of a SSI, but as recommended by the CDC in their 
definition of different SSI types - reiterate the need to correlate the same with “hard” 
clinical signs and symptoms. 
Among the cases who developed SSI – 42 were culture positive while 27 were culture 
negative. Prevalent bacteria and their most sensitive antibiotic pattern cultured from the 
wound in the order of frequency is – 
1st :Escherichia coli ( Amikacin → Cefotaxime → Netilmycin ) 
2nd :Staphyloccus aures ( Amikacin → Amoxycillin → Imipenam ) 
3rd :Klebsiella Sp., Pseudomonas Sp. and Proteus Sp.  ( maximum sensitivity to Amikacin ), 
Followed by Streptococcus sp. and CONS. 
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ASEPSIS score and its results : 
The maximum ASEPSIS score was noted at the height of infection in each infected wound. 
Average scores in –  
 Class I Class II 
CONTROL GROUP 26.75 27.35 
PROPHYLACTIC ANTIBIOTIC 
GROUP 
34.25 25.65 
CLOSED SUCTION DRAINAGE 
GROUP 
21 26.24 
 
 
The above table when interpreted would allow the observer to state that – 
 In class I wounds : Average ASEPSIS scores were least in the closed suction drainage 
group followed by the control and prophylactic antibiotic groups. Therefore class I 
wounds which develop SSIs are least extensive in the closed suction drainage group. 
 In class II wounds : Average ASEPSIS scores were very clustered close together with  
least in the prophylactic antibiotic group followed by the closed suction drainage and 
control groups. Therefore class II wounds which develop SSIs are least extensive in 
the prophylactic antibiotic  group. 
Thus, the presence of either intervention should reduce the severity and extent of the SSI 
developing in a Class I and II wound. 
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Modalities of treatment : 
The occurrence of seropurulent discharge, erythema and wound dehiscence with or without 
fever confirmed the presence of a wound infection. The wound sutures were removed in 
the area of discharge or bulge and fluid was let out. Wound swab was taken at this juncture. 
Wound wash with saline and hydrogen peroxide (if adherent slough present) given. Depth 
of the wound examined for involvement of deeper musculo-fascial planes. Appropriate 
debridement under local anaesthesia done.( note : no case in this trial required 
debridement under regional or general anaesthesia ) If deep/organ space involvement was 
suspected, it was ruled out by appropriate radiological investigations like superficial 
ultrasonography or contrast study.  
Empirical antibiotics were instituted based on prevalent bacterial and sensitivity patterns. 
The antibiotics were changed according to culture and sensitivity patterns when reports 
became available. Daily wound inspection with appropriate debridement and dressings 
continued till infection subsided. Wounds allowed to heal by secondary intention if of the 
superficial incisional type, if failed secondary suture closure was done. Wounds of deep 
incisional type were all closed secondarily in layers. Concurrent strict glycemic and BP 
control, improvement of haemoglobin to more than 10 gms%, hydration and nutritional 
quality and quantity were ensured. 
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Best intervention for prevention of SSIs : 
The null hypotheses was proposed – that no intervention is superior to either intervention 
viz. Prophylactic antibiotic or closed suction drainage in each class of surgery.  
On gross examination (on comparing percentage incidences of SSIs) – 
1. No intervention vs. Prophylactic antibiotic 
Class I - 36.84 % vs. 18.18 % 
Class II -51.51 % vs. 27.42 % 
2. No intervention vs. Closed suction drainage  
              Class I -  36.84 % vs. 7.69 % 
 Class II – 51.51 % vs. 17.65 % 
The above percentages would clearly indicate that in both classes of operations ( I and II ) 
the use of either intervention would reduce the incidence of SSIs. 
The data also suggests that the use of closed suction drainage is superior to the use of 
prophylactic antibiotics in the prevention of SSIs in both Class I and II surgeries. However 
these findings need to be tested using appropriate statistical tests of significance.  
Tests of statistical significance  ( Fischer’s test and chi square test ) -  for discrete data 
performed to test the hypotheses. 
Results : 
1. No intervention vs. Prophylactic antibiotic 
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Class I - The two-tailed P value equals 0.2900, not statistically significant 
Class II -The two-tailed P value equals 0.0068, very statistically significant 
2. No intervention vs. Closed suction drainage  
              Class I -  The two-tailed P value equals 0.1006, not statistically significant 
 Class II - The two-tailed P value equals 0.0012, very statistically significant 
Hence based on obtained p values, the Class I difference between incidence rates between 
no intervention and either intervention was purely because of chance or random sampling 
methodology. However the use of either intervention was superior to none in Class II. 
The lower p value of the closed suction drainage comparison against the p value of the 
prophylactic antibiotic group suggests the superior effect of closed suction drainage in the 
prevention of SSIs in Class II operations. 
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CONCLUSIONS AND RECOMMENDATIONS 
The study was conducted for a period of 1 year. All cases were randomly allocated into the 3 
study groups. A large variety of Class I and II operations were included, the maximum being 
hernia repairs with the placement of synthetic meshes as reinforcement. According to the 
definition of SSI, if a prosthetic implant like a mesh is placed, the follow up period is 
extended to 1 year. However in this study the follow up of each patient was upto only 30 
days hence this is a fallacy secondary to the limited period of this study. 
The trial is a hospital based trial hence during inclusion and randomization of subjects, it 
was not preceded by matching and hence the resultant increase in confounding factors. This 
fallacy could be avoided by a population based sample, subsequently matched and then 
randomized. 
The overall incidence of SSI was 31.94 % and the incidence in individual classes ( Class I - 
22.22 % and Class II – 35.19 % ) paralleled previous Indian and international literature.[8, 9, 
11-18] However this trials incidence percentages are grossly larger than international 
literature which probably reflects the lesser standard of peri-operative wound precautions, 
care and management. 
The type of SSIs encountered were mostly Superficial incisional type which is also the most 
common type according to literature.[4-5] 
Most SSIs developed between post op day 3 and 6, which parallels literature. Only 2 cases 
were noted beyond the first week and those too were in “hernia repair with meshes” 
subjects which parallels the need for extended period of follow up/surveillance in the 
definition of SSIs for surgeries with prosthetic implant placement. 
 49 
 
The effect of age on the chance of developing SSIs was studied and was not found to a 
statistically significant to be an independent factor to influence the incidence of SSIs. 
The risk factors predisposing to SSIs were studied.[19-20]  As previously mentioned, since 
environmental and procedural factors were relatively constant, only the host related pre-
existent co morbidities were analysed. Tobacco and alcohol consumption were also 
excluded   and the final list was headed by diabetes mellitus. Others were hypertension, 
anaemia, old age, prolonged preoperative stay ( >14 days ), long duration surgery ( > 4 hours 
) and different immunosuppressive states. Statistical testing of these factors against 
occurrence of SSIs was done – and found to be significant. Therefore the presence of even 
one or two co-existent illnesses could increase the risk of developing SSIs, as supported by 
previous literature. 
Whether the risk of developing SSIs was different in elective or emergency procedures was 
examined statistically and the tests revealed that the risk of development of SSIs was not 
determined by these 2 factors atleast when applied to class I and II wounds. 
The objective assessment of wounds after the development of SSIs was done and scored 
using the ASEPSIS scoring system. This was done to see if class of wound and intervention 
offered could influence the severity of the resultant infection. The data obtained was 
however not as expected – 
In class I wounds : Average ASEPSIS scores were least in the closed suction drainage group 
followed by the control and prophylactic antibiotic groups. Therefore class I wounds which 
develop SSIs are least extensive in the closed suction drainage group. 
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In class II wounds : Average ASEPSIS scores were least in the prophylactic antibiotic group 
followed by the closed suction drainage and control groups. Therefore class II wounds which 
develop SSIs are least extensive in the prophylactic antibiotic  group. 
Therefore the control group was found to have lesser severity when compared to antibiotics 
in class I wounds. The expected outcome was that either intervention should not only 
reduce the incidence but also the severity of infection, in either class of surgery. Also of 
interest is that the aforementioned apparent statistical advantage (in reducing the incidence 
of SSI) of the drain over the prophylactic antibiotic does not seem to also translate to a less 
severe infection (in drains compared to antibiotics) among Class II wounds. 
The expected increase in severity of infection, as evident by average respective class wise 
ASEPSIS scores in Class II ( 26.41% ) when compared to Class I (27.33% ) wounds was also 
not evident. 
These unexpected results could be due to early intervention of the wound and not allowing 
the wound to course through its natural history and influence maximum ASEPSIS score. 
However, the presence of either intervention should reduce the severity and extent of the 
SSI developing in a Class I and especially in Class II wound. 
All resultant wound exudates were swabbed and sent for microbiological analysis. 
Approximately 60.87 % was found to be positive for an organism. This reiterates the fact 
that culture positivity is not the gold standard for labelling a wound as being infected but an 
adjunct to the diagnosis which is primarily clinical. The resultant pattern of organisms and 
their culture patterns could influence clinicians on the choice of empirical antibiotics once 
infection is noted. These empirical antibiotics are subsequently altered based on swab 
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culture sensitivity patterns. In this trial E.coli was the most prevalent inoculum with a 
predominant sensitivity to Amikacin. 
Finally the null hypothesis was put to the test. Prophylactic antibiotics were given using 
standard dosing and administration protocols ( as described in the Introduction – Antibiotic 
Prophylaxis section and the Methodology section ). Repeat intraoperative dosing was given 
in a few subjects due to prolongation of procedure time beyond 4 hours.  Closed suction 
drainage was achieved with standard 12 - 14F gauge suction tubes connected to syringes or 
appropriate suction devices.  
The analysis of resultant incidence percentages revealed - that in both classes of operations 
(  I and II ) the use of either intervention would reduce the incidence of SSIs. 
The data also suggests that the use of closed suction drainage is superior to the use of 
prophylactic antibiotics in the prevention of SSIs in both Class I and II surgeries. However 
these findings need to be tested using appropriate statistical tests of significance.  
Based on comparing no intervention vs. Each intervention in each class of operation 
individually, the following conclusions were drawn –  
1. In  Class I wounds : neither intervention was found to reduce the SSI incidence when 
compared to no intervention at all 
2. In Class II wounds : both interventions were found to have a statistically significant 
role in reduction of the occurrence of SSIs. The lower P value obtained with the 
closed drainage group compared with the prophylactic antibiotic group when 
individually tested against the control group would suggest a significant superiority 
of drainage to antibiotics in the prophylaxis Class II wounds. 
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These conclusions prevent the indiscriminate use of antibiotic prophylaxis and its resultant 
adverse effects like development of resistance, increased costs, antibiotic side effects in 
both Class I and II wounds. Class I wounds could be managed without any prophylaxis. 
On comparison of the cost incurred during use of either intervention the cost of a simple 
suction catheter and syringe was found to lesser than even a single dose of the prophylactic 
antibiotic. Thus the most cost effective intervention for Class II wounds is the closed suction 
drainage of the subcutaneous space.  
 
FINAL RECOMMENDATIONS : 
 The Class of procedure is an important determinant of the occurrence of SSIs. 
 
 All Class I surgeries do not require any prophylaxis for the prevention of SSIs. 
 
 The most cost effective and rationale prophylactic intervention for Class II 
surgeries is Closed suction drainage of the subcutaneous dead space followed by 
Prophylactic antibiotic use, in the prevention of SSIs. 
 
 The occurrence of SSIs in elective and emergency procedures does not differ and 
hence the prophylaxis would be dictated according to class of wound instead. 
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 The presence of predisposing factors would influence the possibility of developing a 
SSI and hence must be controlled/negated in the preoperative period and the 
patient must be cautiously followed in the post operative period. 
 
 Standard antibiotic prophylaxis regimens must be followed [ 7, 25, 42-46, 38-39, 47-
50 ] – as used in this trial → [ form a protocol wherein appropriate antibiotic is used 
for the appropriate procedure and dictated by prevalent hospital and community 
culture sensitivity patterns; usual therapeutic dose used; IV route used, administered 
within 1 hour of incision or at induction; repeat intra op doses based on time elapsed 
since incision or fluid loss/dilution ] 
 
 Wound infection must be identified early by clinical and bacteriological methods. 
Appropriate management must be instituted determined by plane of affection and 
severity including letting out of exudate, debridement and empirical antibiotics. 
These empirical antibiotics must also be based on prevalent culture – sensitivity 
patterns and changed according to wound swab reports. Other supportive measures 
must be instituted to improve the wound healing environment. 
 
 Regular wound and antibiotic audits must be conducted in the institution. These 
appraisals would allow the clinician to adapt to the constantly changing scenarios 
regarding SSIs. 
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ANNEXURE I – PROFORMA 
 
Name :     Study group : 1-3  
Age : 
Sex : 
IP No. : 
Weight : 
ASA class : 
DOA :                              DOS :                          DOD: 
Diagnosis : 
Procedure done : 
Findings : 
 
Procedure time : 
Elective / Emergency 
Wound Class : 
 
Antibiotic used and regimen : 
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DT used : 
Daily DT output (vol./nature) : 
 
 
DT removed on day _____ 
Signs and symptoms suggestive of SSI and POD of occurrence : 
 
Cultures : 
 
Radiological investigations (if any) : 
ASEPSIS score : 
Review of wound : 
Treatment given (if any) : 
 
Predisposing factors (tick as appropriate) : 
1. Host : co-morbidities (like obesity, malnutrition, immunosuppression, anaemia, uraemia, 
jaundice, diabetes) , alcohol and tobacco use, duration of pre-operative hospital stay, 
remote site infection 
 
 63 
 
2. Environmental : microbe related (viz. Pathogen, virulence and resistance profile), theatre 
environs (viz. Previous case operated) 
 
3. Procedure : Pre-op preparation like shaving/bathing, sterile techniques such as hand 
washing/painting/draping/gloving, meticulous technique like handling and devitalization, 
use of diathermy, haemostasis 
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ANNEXURE II- MASTER CHART 
Name Stud
y 
grou
p 
Wou
nd 
class 
A
g
e 
S
e
x 
A
S
A 
DO
A-
DO
S 
DO
S-
DO
D 
Diagnosis Procedure  dur
ati
on 
Type of 
surgery 
(em/el) 
Wou
nd 
class 
Antibio
tic 
regime
n 
Daily DT output 
and nature 
DT 
remo
val 
day 
S/O SSI SSI 
PO
D 
Culture Treatment Asep
sis 
score 
R/w Predisposing 
thang
araj 
1 1 1 1 I <14 >14 lt congenital 
hernia 
lt herniotomy 1 1 1 no no no erythema, ser 
exudate(<20%) 
4 no 1&3 17 POD5-as 
noted and 
POD30-WNL 
  
Samsu
din 
1 2 4 1 I <14 <14 LIIH hernioplasty 1 1 2 no no no erythema+ pus(40%) 4 Staph 
aureus - 
amikacin 
1 37 POD5-as 
noted and 
POD30-WNL 
  
vasant
hi 
1 2 3 2 II <14 >14 benign GOO TV+GJ 1 1 2 no no no erythema+ ser 
exudate (40%) 
4 no 1&3 21 POD5-as 
noted and 
POD30-WNL 
1(obesity) 
mathu 1 2 5 1 II <14 <14 RDIH hernioplasty 1 1 2 no no no erythema+s/p 
exudate(<25%) 
4 no 1&3 21 POD5-as 
noted and 
POD30-WNL 
  
bhara
nini 
1 2 3 2 I <14 <14 paraumbilical 
hernia 
anatomical&m
esh repair 
1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
malat
hi 
1 2 3 2 I <14 <14 paraumbilical 
hernia 
anatomical&m
esh repair 
1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
rani 1 2 3 2 II >14 >14 appendicitic appendicectom
y 
1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(DM) 
deva 1 1 3 1 I <14 <14 B/L varicose 
veins 
B/L 
trendelenburg 
1 1 1 no  no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
parth
asarth
i 
1 1 4 1 I <14 <14 B/L varicose 
veins 
B/L 
trendelenburg 
1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
krithik
a 
1 1 2 2 I <14 <14 cystic lesion 
thigh?hydatid 
excision 1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
parko
di 
1 1 4 2 II >14 <14 SN Thyroid Hemithyroidect
omy 
1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
moha
mmed 
1 2 2 1 I <14 <14 RDIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
natha
n 
1 2 2 1 I <14 <14 RIIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
janard
han 
1 2 2 1 I <14 <14 RIIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Jitend
ra 
1 2 3 1 I <14 <14 RIIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
gunas
ekar 
1 2 3 1 I <14 <14 RIIH hernioplasty 1 1 2 no  no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
pursh
otham 
1 2 3 1 I <14 <14 RDIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
mani 1 2 3 1 I <14 <14 RIIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Subra
mani 
1 2 4 1 I <14 <14 LIIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
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POD30-WNL 
eluma
lai 
1 2 4 1 I <14 <14 LIIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(old 
age+HTN) 
ravi 1 2 4 1 I <14 <14 RDIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Subra
mani 
1 2 5 1 I <14 <14 RIIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
chalap
athy 
1 2 6 1 II >14 <14 RIIH hernioplasty 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
sethu 1 2 4 1 I <14 <14 R irreducible 
inguinal hernia 
hernioplasty 
with partial 
omentectomy 
1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
anand 1 1 1 1 I <14 <14 rt congenital 
hernia 
herniotomy 1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
sarava
nan 
1 1 1 1 I <14 <14 rt. Cong hernia herniotomy 1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
kanna
n 
1 1 1 1 I <14 <14 rt congenital 
hernia 
herniotomy 1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
logesh
wari 
1 1 3 2 I <14 <14 umb hernia mayo repair 1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Ushan
andini 
1 1 1 2 I <14 <14 MNG NT 
thyroidectomy 
1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
devi 1 2 4 2 I <14 <14 GSD open chole 1 1 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
aman
ullah 
1 2 4 1 II <14 <14 ca stomach palliative 
bypass 
1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(malignancy
) 
Salma 1 1 1 2 I >14 <14 thyroglossal 
cyst 
sistrunk 
operation 
1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
murug
an 
1 1 5 1 II <14 <14 B/L varicose 
veins 
vein stripping 1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
anand
han 
1 2 5 1 II <14 <14 RDIH hernioplasty 1 1 2 no no no pur 
exudate+erythema(20
%) 
15 pseudo-
amik 
1&3 31 POD5-as 
noted and 
POD30-WNL 
1(old age 
and DM) 
vijaya
n 
1 2 5 1 II <14 <14 LDIH hernioplasty 1 1 2 no no no pur 
exudate+erythema(40
%) 
4 cons-amik 1&3 34 POD5-as 
noted and 
POD30-WNL 
1(DM+old 
age) 
punith
amma
l 
1 2 5 1 II <14 >14 paraumbilical 
hernia 
anatomical & 
mesh repair 
1 1 2 no no no pur 
exudate+erythema+m
uscle necrose(50%) 
4 klebsiella - 
amikacin 
1&3 50 POD5-as 
noted and 
POD30-WNL 
1(HTN) 
bhava
ni 
1 2 2 2 I <14 <14 appendicitic appendicectom
y 
1 1 2 no no no pus+erythema(25%) 4 Proteus-
Cefotax 
1&3 21 POD5-as 
noted and 
POD30-WNL 
  
karpas
wamy 
1 2 5 1 II <14 <14 LDIH hernioplasty 1 1 2 no no no pus+erythema(25%) 25 staph-
amik 
1&3 31 POD5-as 
noted and 
POD30-WNL 
1(DM) 
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giridh
ar 
1 2 2 1 I <14 <14 RIIH hernioplasty 1 1 2 no  no no pus+erythema(30%) 4 e. coli-
amik 
1&3 31 POD5-as 
noted and 
POD30-WNL 
  
ponni 1 2 3 2 II <14 <14 inc hernia mesh repair 1 1 2 no no no pus+erythema(40%) 4 CONS-
erythro 
1&3 34 POD5-as 
noted and 
POD30-WNL 
  
sushe
ela 
1 2 3 2 II <14 <14 GB stones open chole 1 1 2 no no no pus+erythema(40%) 4 proteus-
amik 
1&3 34 POD5-as 
noted and 
POD30-WNL 
1(DM) 
rani 1 1 5 2 II <14 >14 ant abd. 
Lipoma 
excision 1 1 1 no no no pus+erythema(80%) 5 staph-
amoxy 
1&3 50 POD5-as 
noted and 
POD30-WNL 
1(old age) 
jayapr
iya 
1 1 1 2 I <14 <14 cystic 
hygroma-neck 
excision 1 1 1 no no no pus+erythems(30%) 4 kleb- 
amikacin 
1&3 21 POD5-as 
noted and 
POD30-WNL 
  
jeeva 1 1 2 1 I <14 <14 lt lipoma excision 1 1 1 no no no ser exudate + 
erythema(25%) 
4 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
  
deepa
k 
1 2 3 1 I <14 <14 RIIH hernioplasty 1 1 2 no no no ser exudate+ 
erythema(30%) 
5 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
  
maha
devan 
1 2 3 1 I <14 <14 malign 
histiocytosis 
laparotomy 
&biopsy 
1 1 2 no no no ser 
exudate+erythema(20
%) 
4 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
  
kanth
a 
1 2 1 2 I <14 <14 RIIH hernioplasty 1 1 2 no no no ser 
exudate+erythema(30
%) 
5 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
  
deepa
k 
1 2 3 1 I <14 <14 LIIH hernioplasty 1 1 2 no no no ser 
exudate+erythema(30
%) 
4 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
1(DM) 
ainava
n 
1 1 3 1 I <14 <14 hydrocoele S/T excision 1 1 1 no no no ser 
exudate+erythema(30
%) 
4 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
  
mani 1 1 3 1 II <14 <14 hydrocoele S/T excision 1 1 1 no no no ser 
exudate+erythema(30
%) 
4 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
  
laksh
mi 
1 1 2 2 I <14 <14 Rt SNT Hemithyroidect
omy 
1 1 1 no no no ser 
exudate+erythma(30
%) 
5 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
  
logan
athan 
1 2 6 1 II <14 <14 LDIH hernioplasty 1 1 2 no no no ser+erythema(20%) 4 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
1(DM+HTN) 
anjali 1 2 2 2 I <14 <14 appendicitic appendicectom
y 
1 1 2 no no no ser+erythema(25%) 3 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
  
seeth
aram 
1 2 3 1 I <14 <14 LIIH hernioplasty 1 1 2 no no no ser+erythema(30%) 4 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
  
palani 1 2 3 2 I <14 <14 RIIH hernioplasty 1 1 2 no no no ser+erythema(30%) 5 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
  
sriniva
san 
1 2 5 1 II <14 <14 RDIH hernioplasty 1 1 2 no no no ser+erythema(30%) 4 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
1(DM) 
bala 1 2 3 1 I <14 <14 LIIH hernioplasty 1 1 2 no no no ser+erythema(50%) 4 no 1&3 21 POD5-as 
noted and 
POD30-WNL 
  
logesh 1 2 5 1 II <14 <14 LDIH hernioplasty 1 1 2 no no no ser+erythema(50%) 4 no 1&3 21 POD5-as 
noted and 
POD30-WNL 
1(old age) 
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vasant
ha 
1 2 3 2 I <14 <14 cholelithiasis open chole 1 1 2 no no no serosanguinous 
d/s(<20%) 
5 no 1 19 POD5-as 
noted and 
POD30-WNL 
  
Anton
y 
1 1 4 1 I >14 <14 splenic infarct 
cyst 
splenectomy 1 1 1 no no no seroupurulent 
d/s(50%) 
3 staph 
aureus -
Amoxicilli
n 
3 50 POD5-as 
noted and 
POD30-WNL 
  
Abdul 1 2 3 1 I <14 <14 RIIH hernioplasty 1 2 2 no no no erythema+serous 
d/s(30%) 
3 no 1&3 37 POD5-as 
noted and 
POD30-WNL 
  
dhanp
al 
1 2 1 1 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
munis
wamy 
1 2 1 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Nand
hini 
1 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
kalpa
na 
1 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
sathya 1 2 1 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
soniya 1 2 1 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Sivaku
mar 
1 2 2 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
murug
an 
1 2 2 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
ravi 1 2 2 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(malignancy
) 
gopin
ath 
1 2 2 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no  no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Vetris
elvi 
1 2 2 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Sumat
hi 
1 2 2 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
jaya 1 2 2 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
pari 1 2 3 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
sitalak
shmi 
1 2 2 2 II <14 >14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no pur 
exudate+erythema+m
uscle necrosis (50%) 
deep inc 
5 pseudo-
cefotax 
2&3 55 POD5-as 
noted and 
POD30-WNL 
1(obesity) 
damo
dar 
1 2 2 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no pus+erythema(25%) 4 e.coli-
amik 
1&3 31 POD5-as 
noted and 
POD30-WNL 
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sarany
a 
1 2 1 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no pus+erythema(30%) 3 e.coli-
amik 
1&3 31 POD5-as 
noted and 
POD30-WNL 
  
sheela 1 2 2 2 II <14 <14 twisted 
ovarian cyst 
SO 1 2 2 no no no pus+erythema(40%) 4 e.coli-
amik 
1&3 34 POD5-as 
noted and 
POD30-WNL 
  
jeeva 1 2 4 1 II <14 <14 incarc 
RIIH(omentum
) 
hernioplasty 1 2 2 no no no pus+erythema(80%) 3 staph-
imipenem 
1&3(suturin
g) 
40 POD5-as 
noted and 
POD30-WNL 
  
lalitha 1 2 3 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no ser 
exudate+erythema(30
%) 
4 E.coli-
Netil 
1&3 19 POD5-as 
noted and 
POD30-WNL 
  
jaya 1 2 4 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no ser 
exudate+erythema(30
%) 
12 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
1(Dm &old 
age) 
jayam
mal 
1 2 2 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no ser 
exudate+erythema(40
%) 
5 E.coli-
Amik 
1&3 21 POD5-as 
noted and 
POD30-WNL 
  
dhana
shri 
1 2 2 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no ser 
exudate+erythema(60
%) 
4 klebsiella- 
amikacin 
1&3 37 POD5-as 
noted and 
POD30-WNL 
  
nithya 1 2 1 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no ser+erythema(30%) 5 Cons-
erythro 
1&3 29 POD5-as 
noted and 
POD30-WNL 
  
basha 2 2 3 1 II <14 <14 B/L DIH B/L 
hernioplasty 
1 1 2 2 no no erthema+SE(30%) 3 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
1(HIV) 
vidya 2 2 3 2 II >14 >14 paraumbilical 
hernia 
anatomical & 
mesh repair 
1 1 2 2 no no erythema+ pur. 
Exudate(50%) 
5 staph-
amoxy 
1&3(mesh 
removal 
&suturing) 
44 POD5-as 
noted and 
POD30-WNL 
1(anemia&o
besity) 
varad
haraja
n 
2 1 5 1 II <14 <14 epigastric 
hernia 
anatomical 
repair 
1 1 1 1 no no erythema+seropurule
nt d/s(40%) 
6 pseudom
onas - 
imipenem 
3 39 POD5-as 
noted and 
POD30-WNL 
1(obesity) 
kamin
i 
2 1 4 2 II <14 <14 epigastric 
hernia 
anatomical 
repair 
1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
kutti 2 2 3 1 II <14 <14 B/L IIH B/L 
hernioplasty 
1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
chinn
adurai 
2 2 1 1 I <14 <14 pseudocyst CG 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
babu 2 2 6 1 II <14 <14 distal panr 
pseudocyst+sp
lenic infarct 
distal 
pancreatectom
y+splenectomy 
2 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(old age) 
gowri
amma
l 
2 1 1 2 II <14 <14 NHL-axillary LN excision 1 1 1 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(malignancy
) 
rames
h 
2 1 2 1 I <14 <14 ankle bursa excision 1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
asif 2 1 2 1 I <14 <14 lipoma excision 1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
kanna
n 
2 1 5 1 II <14 <14 lipoma excision 1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(old age) 
david 2 1 1 1 I <14 <14 rt.thigh lipoma excision  1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
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shama
la 
2 1 4 2 II >14 <14 Rt. Cervical 
Lnpathy 
excision biopsy 1 1 1 2 no  no no no no no no POD5-as 
noted and 
POD30-WNL 
  
vedha 2 1 5 2 I <14 <14 ?LN neck-
parotid 
excision biopsy 1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
ranjini 2 1 2 2 I <14 <14 Rt. SNT Hemithyroidect
omy 
1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
vasant
ha 
2 2 4 1 I <14 <14 RIIH herioplasty 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
selva
m 
2 2 2 1 I <14 <14 RIIH hernioplasty 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Gajen
dran 
2 2 3 1 I <14 <14 RIIH hernioplasty 1 1 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
radha
mani 
2 2 3 1 I <14 <14 LIIH hernioplasty 1 1 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
prakas
h 
2 2 3 1 I <14 <14 LIIH hernioplasty 1 1 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
sanive
l 
2 2 3 1 II <14 <14 RDIH hernioplasty 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
prade
ep 
2 2 3 1 II <14 <14 RIIH hernioplasty 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
pandi
yan 
2 2 4 1 I <14 <14 LIIH hernioplasty 1 1 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
abdul 
rahma 
2 2 4 1 II <14 <14 LDIH hernioplasty 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(DM+HTN) 
lazaru
s 
2 2 4 1 II <14 <14 RIIH hernioplasty 2 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(COPD) 
bhask
ar 
2 2 4 1 II <14 <14 RDIH hernioplasty 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(HTN+old 
TB) 
subra
mani 
2 2 4 1 II <14 <14 RDIH hernioplasty 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(HTN) 
balara
man 
2 2 5 1 II <14 <14 LIIH hernioplasty 1 1 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
naray
anasw
amy 
2 2 6 1 II <14 <14 RIIH hernioplasty 1 1 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
shank
ar 
2 1 1 1 I <14 <14 rt. Cong. 
Hydrocoele 
herniotomy 1 1 1 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Aman
ullah 
2 2 5 1 II <14 <14 LDIH and 
hydrocoele 
herniplasty & 
eversion 
1 1 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
rani 2 1 3 2 I <14 <14 femoral hernia high op 1 1 1 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
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adilak
shmi 
2 1 1 2 II >14 <14 Lt solitart 
nodule thyroid 
Lt 
hemithyroidect
omy 
1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
dhana
sekar 
2 1 1 1 I <14 <14 Lt testis 
chronic torsion 
Lt. high inguinal 
orchidectomy 
1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
vedha 2 1 5 2 II <14 <14 LN+Ca parotid MRND+total 
parotidectomy 
2 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(malignancy
) 
neela
mmal 
2 2 5 2 II <14 <14 GSD open chole 1 1 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(old age) 
giri 2 1 3 1 II >14 <14 Carcinoma 
stomach 
Palliative 
Anterior GJ 
with JJ 
1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
fathim
a 
2 2 5 2 II <14 <14 ilial knotting release 1 1 2 2 no  no  no no no no no POD5-as 
noted and 
POD30-WNL 
1(old age) 
janika
ran 
2 1 3 1 I <14 <14 hydrocoele S/T excision 1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
sahira 2 1 1 2 I <14 <14 thyroglossal 
cyst 
sistrunk 
operation 
1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
yuvar
ani 
2 2 3 2 II <14 <14 rt dermoid 
ovary 
SO 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(malignancy
) 
malat
hi 
2 2 3 2 I <14 <14 multiple 
fibroids 
TAH 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
thang
avel 
2 2 4 1 II <14 <14 GOO TV+GJ 1 1 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
sekar 2 2 3 1 II >14 <14 CCP+splenic 
infarct 
distal 
pancreatectom
y+splenectomy 
2 1 2 2 no no pur 
exudate+erythema(20
%) 
4 no 1&3 21 POD5-as 
noted and 
POD30-WNL 
1(DM) 
vaithis
waran 
2 2 5 1 II <14 <14 RDIH hernioplasty 1 1 2 2 no no pur 
exudate+erythema(20
%) 
5 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
1(old PT, old 
age) 
ganes
an 
2 2 2 1 I <14 <14 post ileostomy reanastomosis 1 1 2 2 no no pur 
exudate+erythema(30
%) 
4 ecoli-
cefotax 
1&3 31 POD5-as 
noted and 
POD30-WNL 
  
meera 2 2 4 2 II <14 >14 fibroids TAH 1 1 2 2 no no pur 
exudate+erythema(40
%) 
6 staph-
imipenem 
1&3 44 POD5-as 
noted and 
POD30-WNL 
1(DM) 
munu
swam
y 
2 2 3 1 II >14 >14 RIIH&Rt. 
Hydrocoele 
hernioplasty& 
eversion of sac 
1 1 2 1 no  no purulent d/s (20%) 2 Staph 
aureus - 
amikacin 
3 17 POD5-as 
noted and 
POD30-WNL 
  
chengi
yan 
2 2 4 1 II <14 >14 cholelithiasis open chole 1 1 2 1 no no purulent d/s (20%) 3 Staph 
aureus - 
amikacin 
3 19 POD5-as 
noted and 
POD30-WNL 
  
swami
natha
n 
2 1 4 1 II <14 >14 ca penis rt I/I block 
dissection 
1 1 1 1 no no purulent 
d/s+erythema (~75%) 
4 klebsiella - 
amikacin 
1&3(second
ary 
suturing) 
47 POD5-as 
noted and 
POD30-WNL 
1(malignancy
) 
senthi
l 
2 1 1 1 I <14 <14 paracytic cyst 
rt thigh 
excision 1 1 1 no no no pus+erythema(40%) 5 e.coli-
cefotax 
1&3 34 POD5-as 
noted and 
POD30-WNL 
  
sheik 
hassa
n 
2 2 4 1 II <14 <14 LDIH hernioplasty 1 1 2 2 no no pus+erythema(70%)d
eep inc 
4 klebsiella - 
amikacin 
1&3 45 POD5-as 
noted and 
POD30-WNL 
1(obesity& 
HTN) 
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periya
swam
y 
2 2 3 1 II <14 <14 LDIH hernioplasty 1 1 2 2 no no ser 
exudate+erythema(20
%) 
4 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
1(DM) 
thoma
s 
2 2 6 1 II <14 >14 Lt recurrent, 
RDIH 
b/l hernioplasty 2 1 2 2 no no ser 
exudate+erythema(70
%) b/l 
5 E.coli-
Amik 
1&3 33 POD5-as 
noted and 
POD30-WNL 
1(old 
laryngeal ca 
on RT, old 
age) 
nanda
kumar 
2 2 5 1 II <14 <14 LDIH hernioplasty 1 1 2 2 no no ser+erythema(25%) 4 no 1&3 19 POD5-as 
noted and 
POD30-WNL 
1(old 
age+HTN) 
jancy 
rani 
2 1 2 2 II <14 <14 NG Lt thyroid 
lobe 
Lt 
hemithyroidect
omy 
1 1 1 2 no no serous d/s(<20%) 7 no 1 17 POD5-as 
noted and 
POD30-WNL 
  
mang
amma
l 
2 2 2 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no erythema+ ser. 
Exudate(<25%) 
3 proteus -
Amikacin 
1&3 31 POD5-as 
noted and 
POD30-WNL 
  
nanda
kumar 
2 2 1 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
hansr
aj 
2 2 1 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
ravi 2 2 1 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
syed 2 2 1 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
narya
nan 
2 2 1 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
devar
uban 
2 2 1 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
vasant
hi 
2 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
dhivya
vani 
2 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 1 no   no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Rathn
a 
2 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
varala
kshmi 
2 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
devi 2 2 1 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
kumar 2 2 1 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
poong
udi 
2 2 1 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
latha 2 2 1 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
Subra
mani 
2 2 2 1 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 1 no no no no no no no POD5-as 
noted and 
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POD30-WNL 
mahal
akshm
i 
2 2 2 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
anna
mmal 
2 2 2 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
1(HTN) 
banu
mathi 
2 2 2 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
muth
ukrish
nan 
2 2 3 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
rafiq 2 2 3 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
babu 2 2 3 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
bhara
thi 
2 1 2 2 II <14 <14 twisted broad 
ligament cyst 
excision 1 2 1 2 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
masila
mani 
2 2 6 1 II <14 <14 RIIH hernioplasty 1 2 2 1 no  no no no no no no POD5-as 
noted and 
POD30-WNL 
  
nazee
ma 
2 2 2 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 1 no no purulent d/s(<20%) 3 kleb- 
amikacin 
3 17 POD5-as 
noted and 
POD30-WNL 
  
rajam
mal 
2 2 4 2 II <14 <14 adhesive 
obstruction 
adhesiolysis 1 2 2 2 no no pus+erythema(40%) 5 CONS-
amox 
1&3 34 POD5-as 
noted and 
POD30-WNL 
  
arun 2 2 2 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 2 no no ser 
exudate+erythema(<2
0%) 
3 no 1&3 17 POD5-as 
noted and 
POD30-WNL 
  
rames
h 
2 2 2 1 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 1 no no seropurulent 
d/s(<20%) 
3 pseudo-
cefotax 
1 17 POD5-as 
noted and 
POD30-WNL 
  
rajend
ran 
3 1 3 1 I <14 <14 epigastric 
hernia 
anatomical 
repair 
1 1 1 no 8ml;5ml;4ml;2
ml(serosanguin
ous);nil 
5 no no no no no POD5-as 
noted and 
POD30-WNL 
  
thaith
ri 
3 1 2 2 II <14 <14 pap ca completion 
thyroidectomy 
1 1 1 no 15ml;5ml;nil 4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
thatha
thri 
3 1 2 2 II >14 <14 Rt SNT Hemithyroidect
omy 
1 1 1 1 no no no no no no no POD5-as 
noted and 
POD30-WNL 
  
ganes
h 
3 2 1 1 II <14 <14 RIIH hernioplasty 1 1 2 no 5ml; 3ml; 
minimal 
4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
jayaku
mar 
3 2 2 1 I <14 <14 RDIH hernioplasty 1 1 2 no 5ml:4ml:nil 3 no no no no no POD5-as 
noted and 
POD30-WNL 
  
ashwi
n 
3 2 2 1 I <14 <14 RDIH hernioplasty 1 1 2 no 8ml;3ml;nil 4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
kumar 3 2 3 1 I <14 <14 RIIH hernioplasty 1 1 2 no 8ml;5ml;nil(ser
osang) 
7 no no no no no POD5-as 
noted and 
POD30-WNL 
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sathya
naray
ana 
3 2 4 1 II <14 <14 LIIH hernioplasty 1 1 2 no 8ml;nil 5 no no no no no POD5-as 
noted and 
POD30-WNL 
  
krishn
an 
3 2 4 1 I <14 <14 LDIH hernioplasty 1 1 2 no 8ml;6ml;nil 3 no no no no no POD5-as 
noted and 
POD30-WNL 
  
vedha
chala
m 
3 2 5 1 II <14 <14 LIIH hernioplasty 1 1 2 no 7ml;5ml;5ml;4
ml(serosanguin
ous);nil 
5 no no no no no POD5-as 
noted and 
POD30-WNL 
  
panch
achar
am 
3 2 6 1 I <14 <14 RIIH hernioplasty 1 1 2 no 10ml;5ml;nil(se
rosang) 
7 no no no no no POD5-as 
noted and 
POD30-WNL 
  
Manik
andan 
3 1 1 1 I <14 <14 RIIH hernioraphy 1 1 1 no 8ml;5ml;3ml;m
inimal(serosan
guinous) 
4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
suresh 3 1 1 1 I <14 <14 RIIH herniorraphy 1 1 1 no 12ml'7ml;4ml;
nil(sersang) 
4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
barani 3 1 2 1 I <14 <14 RIIH herniorraphy 1 1 1 no 5ml;minimal 4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
Pandi
yan 
3 1 1 1 I <14 <14 lt. cong hernia herniotomy 1 1 1 no 5ml;nil 2 no no no no no POD5-as 
noted and 
POD30-WNL 
  
sridar 3 1 1 1 I <14 <14 Lt testis  
torsion 
Lt LIO 1 1 1 no <2ml;nil 2 no no no no no POD5-as 
noted and 
POD30-WNL 
  
savith
ri 
3 2 5 2 II <14 <14 incisional 
hernia 
mesh repair 1 1 2 no 40ml;5ml(seros
ang) 
8 no no no no no POD5-as 
noted and 
POD30-WNL 
1(diabetes) 
valaim
athi 
3 2 4 2 II <14 <14 GSD open chole 1 1 2 no 8ml;4ml;nil 4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
deva 3 2 5 1 II >14 <14 benign GOO TV+GJ 1 1 2 no 8ml;<2ml;nil 5 no no no no no POD5-as 
noted and 
POD30-WNL 
  
shoba
na 
3 1 1 2 I <14 >14 rt breast cyst WLE 1 1 1 no 12ml;5ml;nil 6 no no no no no POD5-as 
noted and 
POD30-WNL 
  
manor
mani 
3 1 4 2 II <14 <14 Lt breast ca WLE 1 1 1 no 10ml;2ml;nil 6 no no no no no POD5-as 
noted and 
POD30-WNL 
1(malignancy
) 
rathn
amma
l 
3 1 4 2 I <14 <14 breast cyst WLE 1 1 1 no 20ml;8ml;nil 6 no no no no no POD5-as 
noted and 
POD30-WNL 
  
dhana
laksh
mi 
3 2 3 2 II <14 >14 incisional 
hernia 
anatomical & 
mesh repair 
1 1 2 no 20ml;15ml;faile
d 
4 pur 
exudate+erythema(60
%) 
4 strpt-
imipenem 
1&3(mesh 
removal 
&suturing) 
47 POD5-as 
noted and 
POD30-WNL 
1(HTN) 
mumt
az 
3 2 4 2 I <14 >14 incisional 
hernia 
anatomical & 
mesh repair 
1 1 2 no 25ml;15ml;faile
d 
3 pur 
exudate+erythema(60
%) 
4 pseudo-
amik 
1&3(mesh 
removal 
&suturing) 
47 POD5-as 
noted and 
POD30-WNL 
  
chella
mmal 
3 2 6 2 II <14 >14 incisional 
hernia 
anatomical & 
mesh repair 
1 1 2 no 20ml;15ml;faile
d 
5 pus+erythema(100%) 4 pseudo-
amik 
1&3(mesh 
removal 
&suturing) 
50 POD5-as 
noted and 
POD30-WNL 
1(old age) 
shakir
a 
banu 
3 2 4 2 II <14 >14 inc hernia+GB 
stones 
chole+mesh 
repair 
1 1 2 no 20ml;5ml;nil 6 pus+erythema(40%) 5 e.coli-
cefotax 
1&3 44 POD5-as 
noted and 
POD30-WNL 
1(DM) 
suloch
ana 
3 1 4 2 II >14 <14 irreducible 
umbilical 
hernia 
anatomical 
repair 
1 2 1 no 15ml;30ml;20
ml 
7 induration& purulent 
d/s (20%) 
5 proteus - 
Amikacin 
3 21 POD5-as 
noted and 
POD30-WNL 
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selvi 3 1 2 2 I <14 <14 incisional 
hernia 
anatomical 
repair 
1 2 1 no 50ml;15ml;min
imal(serosang) 
6 no no no no no POD5-as 
noted and 
POD30-WNL 
  
vikra
m 
3 2 1 1 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 5ml;1ml;nil 3 no no no no no POD5-as 
noted and 
POD30-WNL 
  
karthi
keyan 
3 2 1 1 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 5ml;3ml;nil(ser
osang) 
5 no no no no no POD5-as 
noted and 
POD30-WNL 
  
sahee
b 
3 2 1 1 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 7ml;2ml;minim
al 
6 no no no no no POD5-as 
noted and 
POD30-WNL 
  
arulku
mar 
3 2 1 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 5ml;3ml;nil(ser
osang) 
3 no no no no no POD5-as 
noted and 
POD30-WNL 
  
prabh
u 
3 2 1 1 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 9ml;2ml;nil 5 no no no no no POD5-as 
noted and 
POD30-WNL 
  
rajesh
wari 
3 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 4ml; 3ml 2 no no no no no POD5-as 
noted and 
POD30-WNL 
  
gopik
a 
3 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 4ml;3ml;nil(ser
osang) 
3 no no no no no POD5-as 
noted and 
POD30-WNL 
  
sarany
a 
3 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 10ml;8;7;5;3;ni
l(serosang) 
7 no no no no no POD5-as 
noted and 
POD30-WNL 
  
Jamun
a 
3 2 1 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 5ml;1.5ml 3 no no no no no POD5-as 
noted and 
POD30-WNL 
  
geeth
a 
3 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 5ml;2ml;nil 4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
nandh
ini 
3 2 1 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 6ml;3ml;nil 4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
sapna 3 2 1 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 3ml;nil 2 no no no no no POD5-as 
noted and 
POD30-WNL 
  
Siva 3 2 2 1 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 6ml;3ml;<2ml 4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
sonia 3 2 2 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 8ml;5ml;nil(ser
osang) 
4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
laksh
mipriy
a 
3 2 2 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 8ml;5ml;nil(ser
osang) 
3 no no no no no POD5-as 
noted and 
POD30-WNL 
  
Subra
mani 
3 2 3 1 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 30ml;3ml 5 no no no no no POD5-as 
noted and 
POD30-WNL 
  
shant
hi 
3 2 3 2 I <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 10ml;4ml;nil 4 no no no no no POD5-as 
noted and 
POD30-WNL 
  
devi 3 2 2 2 II <14 <14 rt twisted 
ovarian cyst 
rt. 
Oopherectomy 
1 2 2 no 10ml;2ml;nil 5 ser 
exudate+erythema(30
%) 
5 proteus-
norflox 
1&3 29 POD5-as 
noted and 
POD30-WNL 
  
jayam
mal 
3 2 2 2 II <14 <14 acute 
appendictis 
appendicectom
y 
1 2 2 no 8ml;3ml;nil 4 ser 
exudate+erythema(35
%) 
3 prot-netil 1&3 29 POD5-as 
noted and 
POD30-WNL 
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